Pedro Figueiredo Ferreira
Nurse Practitioner · Fayetteville, NCNPI 1891401337
Payments from drug & device makers
What this record shows
This record is dominated by other: $30,443 of the $33,215 with a category attached, or 91.7%. Angiodynamics, Inc. accounts for 91.7% of it on its own, with 22 other manufacturers making up the rest. Among nurse practitioner clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $307.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$30K
- AstraZeneca$322
- Scpharmaceuticals Inc.$285
- Boehringer Ingelheim$279
- Merck$229
- Amgen$197
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,7728%
- Other$30,44392%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 10 | $30,443 |
| AstraZeneca | 6 | $322 |
| Scpharmaceuticals Inc. | 4 | $285 |
| Boehringer Ingelheim | 9 | $279 |
| Merck | 13 | $229 |
| Amgen | 11 | $197 |
| Actelion Pharmaceuticals US, Inc. | 4 | $195 |
| Novo Nordisk | 3 | $177 |
| Pfizer | 10 | $160 |
| Johnson & Johnson | 6 | $159 |
| E.r. Squibb & Sons, L.L.C. | 9 | $153 |
| Alnylam Pharmaceuticals Inc. | 2 | $141 |
| Lilly USA, LLC | 1 | $120 |
| Boston Scientific | 3 | $103 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $57 |
| Bayer | 2 | $43 |
| Baxter Healthcare | 2 | $40 |
| Novartis | 2 | $26 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| Edwards Lifesciences | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Cashflow Solutions, LLC | 2 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$22,500
- VenaCure 1470 Pro$7,943
- FUROSCIX$247
- JARDIANCE$242
- UPTRAVI$125
- OPSUMIT$125
- AMVUTTRA$125
- FARXIGA$120
- LOKELMA$120
- XARELTO$107
How this compares
$33,215 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 137 | $136,607 |
| XareltoRivaroxaban | 59 | $56,261 |
| EntrestoSacubitril/Valsartan | 27 | $42,516 |
| JardianceEmpagliflozin | 27 | $24,302 |
| Repatha SureclickEvolocumab | 12 | $12,886 |
| FarxigaDapagliflozin Propanediol | 11 | $10,034 |
| Metoprolol Succinate | 281 | $3,190 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 33 | $943 |
| Ranolazine ErRanolazine | 18 | $912 |
| Potassium Chloride | 43 | $840 |
| Rosuvastatin Calcium | 75 | $783 |
| Losartan Potassium | 108 | $771 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $724 |
| Atorvastatin Calcium | 81 | $673 |
| Hydralazine Hcl | 64 | $672 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $160 | $136,607137 claims |
| Johnson & JohnsonXarelto | $159 | $56,26159 claims |
| NovartisEntresto | $26 | $42,51627 claims |
| Boehringer IngelheimJardiance | $279 | $24,30227 claims |
| AstraZenecaFarxiga | $322 | $10,03411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Fayetteville
- Kimalisa LocklearFayetteville$34K
- Sandrivette JohnsonRaleigh$573K
- Ayeshia WrightMocksville$145K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
- Bridget ArchambaultDurham$57K
- Deborah MayerChapel Hill$55K
- Amber SeilerGreensboro$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.